Balance Sheet
Accounts PayablesAssetsCash & Current InvestmentsCash & EquivalentsCommon EquityCurrent AssetsCurrent Deferred RevenueCurrent LeasesFinished GoodsGoodwillGoodwill & IntangiblesIntangiblesInventoryLiabilities and Shareholders EquityNon-Current AssetsNon-Current DebtOperating LeasesOther Non-Current AssetsOther Non-Current LiabilitiesPayablesPrepaid AssetsProperty, Plant & Equipment (Net)Raw MaterialsReceivablesReceivables - NetRetained EarningsShareholder's EquityShort term DebtTotal Current LiabilitiesTotal DebtTotal LiabilitiesTotal Non-Current LiabilitiesTreasury Shares
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Others
Ratios

ENvue Medical (FEED) Total Liabilities (2017 - 2025)

Historic Total Liabilities for ENvue Medical (FEED) over the last 12 years, with Q3 2025 value amounting to $11.9 million.

  • ENvue Medical's Total Liabilities rose 32416.37% to $11.9 million in Q3 2025 from the same period last year, while for Sep 2025 it was $11.9 million, marking a year-over-year increase of 32416.37%. This contributed to the annual value of $3.0 million for FY2024, which is 1176.47% up from last year.
  • ENvue Medical's Total Liabilities amounted to $11.9 million in Q3 2025, which was up 32416.37% from $11.0 million recorded in Q2 2025.
  • In the past 5 years, ENvue Medical's Total Liabilities ranged from a high of $11.9 million in Q3 2025 and a low of $955000.0 during Q3 2021
  • Moreover, its 5-year median value for Total Liabilities was $2.7 million (2023), whereas its average is $3.8 million.
  • Within the past 5 years, the most significant YoY rise in ENvue Medical's Total Liabilities was 58314.61% (2021), while the steepest drop was 6042.84% (2021).
  • Quarter analysis of 5 years shows ENvue Medical's Total Liabilities stood at $2.3 million in 2021, then increased by 14.6% to $2.6 million in 2022, then grew by 1.51% to $2.7 million in 2023, then grew by 11.76% to $3.0 million in 2024, then soared by 297.04% to $11.9 million in 2025.
  • Its last three reported values are $11.9 million in Q3 2025, $11.0 million for Q2 2025, and $8.4 million during Q1 2025.